Archives of Pharmacal Research

, Volume 32, Issue 8, pp 1103–1108

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases


DOI: 10.1007/s12272-009-1801-1

Cite this article as:
Napoli, C. & Ignarro, L.J. Arch. Pharm. Res. (2009) 32: 1103. doi:10.1007/s12272-009-1801-1


Nitric oxide (NO) is a pivotal signaling messenger in the cardiovascular system. NO participates in regulatory functions including control of hemostasis, fibrinolysis, platelet and leukocyte interactions with the arterial wall, regulation of vascular tone, proliferation of vascular smooth muscle cells, and homeostasis of blood pressure. Diminished NO bioavailability and abnormalities in NO-dependent signaling are among central factors of vascular disease, although it is unclear whether this is a cause of, or result of endothelial dysfunction or both pathogenic events. Disturbances in NO bioavailability have been linked to cause endothelial dysfunction, leading to increased susceptibility to atherosclerotic lesion progression, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis and stroke.

Key words

Nitric oxideAtherosclerosisSmooth muscle cells

Copyright information

© The Pharmaceutical Society of Korea 2009

Authors and Affiliations

  1. 1.Department of General Pathology and Excellence Research Center on Cardiovascular Diseases, Chair of Clinical Pathology, 1St School of MedicineII University of NaplesNaplesItaly
  2. 2.Department of Medical and Molecular PharmacologyUniversity of California Los Angeles, David Geffen School of Medicine, Center for Health SciencesLos AngelesUSA
  3. 3.WCU program, School of MedicineKonkuk UniversitySeoulKorea
  4. 4.Department of General Pathology, 1St School of MedicineII University of NaplesNaplesItaly